SXTC Stock Summary

• China SXT Pharmaceuticals Inc's stock had its IPO on January 4, 2019, making it an older stock than merely 0.02% of US equities in our set.
• SXTC's price/sales ratio is 129.5; that's higher than the P/S ratio of 98.44% of US stocks.
• As for revenue growth, note that SXTC's revenue has grown -83.89% over the past 12 months; that beats the revenue growth of merely 1.25% of US companies in our set.
• Stocks that are quantitatively similar to SXTC, based on their financial statements, market capitalization, and price volatility, are BWFG, DJCO, LEJU, AHPI, and UTI.
• To check out China SXT Pharmaceuticals Inc's SEC filings, go to the company's page on browse-edgar?action=getcompany&CIK=0001723980.